ACHIEVE-CHD Study for Coronary Heart Disease
This study, called ACHIEVE-CHD, is looking for Black or African American individuals aged 40-75 in the Cleveland Metro Area who have coronary heart disease (CHD) and certain risk factors. The goal is to improve heart health and reduce health differences. Participants will be divided into two groups based on their heart disease risk. Those with lower risk (CAC < 100) will work with community health workers using a program called PAL2. Those with higher risk (CAC ≥ 100) will receive care from specialists at CINEMA. Both groups will have their social needs assessed to help with their health plan. The study aims to see how well these approaches help participants meet a "Triple Goal" for their health after 12 months. The current status of this study is unclear, but it plans to enroll 500 participants.
- Study design
- This is an interventional study with a planned enrollment of 500 participants. It compares two different approaches to managing coronary heart disease.
- What's involved
- Participants will be followed by their primary care provider or specialists, and some will have monthly contact with community health workers. The primary endpoint is measured at 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome of the study will be measured at 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Project 3: ACHIEVE- CHD
At a glance
Conditions
NCT05918380
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University Hospitals Cleveland Medical Center
Cleveland, Ohiono site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Sanjay Rajagopalan, MD · PRINCIPAL_INVESTIGATOR · University Hospitals Cleveland Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Triple Goal12 months
Percent reaching triple goal of BP \<130/80 mm Hg, HbA1c\<5.7% and LDL-C \<130 mg/dl (\<100 if high-risk)